Periodic Reporting for period 2 - StaphIMPACT (SA.100: Next-generation targeted antibacterial product entering European market)

According to the WHO, antibiotic resistance is one of humanity’s biggest health threats, claiming ~10 million extra deaths per year and US$100 trillion by 2050, unless alternatives to antibiotics are developed. Micreos has developed the world’s first targeted antibacterial...